NCT00513123View on ClinicalTrials.gov

Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Cervical Cancer
Interventions
PROCEDURE

Colposcopy

As part of routine colposcopic evaluation, patients will undergo routine colposcopy with the digital colposcope (DC) will then be used to take an image of the vagina and cervix.

Trial Locations (5)

77030

Lyndon B. Johnson Hospital, Houston

U.T. Health Science Center, Houston

U.T.M.D. Anderson Cancer Center, Houston

Unknown

British Columbia Cancer Research Center, Vancouver

University College Hospital, Ibadan

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00513123 - Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia | Biotech Hunter | Biotech Hunter